Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

182
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
182
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

234
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
234
One-Compartment Model: IV Infusion01:09

One-Compartment Model: IV Infusion

186
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
186

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same author

Breastfeeding and subsequent risk of 24 types of maternal cancer: a cohort study of Chinese women.

Nutrition journal·2026
Same author

Pharmacokinetics and Customized Dosing of Vancomycin in Adult Patients With Hematological Malignancies: Status, Challenges, and Opportunities.

Pharmacology research & perspectives·2026
Same author

A 3D in vitro model for studying human implantation and implantation failure.

Cell·2025
Same author

First-trimester thyroid reference intervals in twin pregnancy: establishment, diagnostic utility, and association with adverse outcomes.

Frontiers in endocrinology·2025
Same author

Microbial Alliances: Unveiling the Effects of a Bacterial and Fungal Cross-Kingdom SynCom on Bacterial Dynamics, Rhizosphere Metabolites, and Soybean Resilience in Acidic Soils.

Journal of agricultural and food chemistry·2025

Related Experiment Video

Updated: Jun 20, 2025

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.2K

Individualized, dynamic, and full-course vancomycin dosing prediction: a study on the customized dose model.

Xiangqing Song1, Meizi Zeng1, Tao Yang1

  • 1Department of Pharmacy, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

Frontiers in Pharmacology
|July 18, 2024
PubMed
Summary

A new customized dose model (CDM) improves vancomycin therapy by enabling individualized, dynamic dosing. This approach surpasses traditional methods, offering better clinical efficacy and predicting optimal vancomycin dosages for various patient populations.

Keywords:
dynamic administrationindividual deliverymathematical modelingpharmacokinetic/pharmacodynamictherapeutic drug monitoringvancomycin

More Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.4K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K

Related Experiment Videos

Last Updated: Jun 20, 2025

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.2K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.4K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K

Area of Science:

  • Pharmacology and Pharmaceutical Sciences
  • Clinical Pharmacy
  • Mathematical Modeling in Medicine

Background:

  • Current therapeutic drug monitoring (TDM) and Bayesian forecasting for vancomycin have limitations in achieving individualized and dynamic drug delivery.
  • There is a need for integrated pharmacokinetic/pharmacodynamic (PK/PD) and TDM approaches to create customized dose models (CDM) for precise vancomycin treatment.

Purpose of the Study:

  • To establish a customized dose model (CDM) for vancomycin.
  • To evaluate CDM's performance and superiority in predicting clinical efficacy compared to existing models.
  • To develop a CDM-driven strategy for individualized, dynamic, and full-course vancomycin dose prediction, including empirical dosing for specific patient and bacterial profiles.

Main Methods:

  • Established CDM using previously derived PK/PD and concentration models.
  • Utilized receiver operating characteristic (ROC) curves and area under the ROC curve (AUC_R) to assess CDM's predictive performance against the frequently-used dose model (FDM) in 21 retrospective cases.
  • Formulated a CDM-driven dosing strategy and employed Monte Carlo simulations to predict empirical vancomycin dosages.

Main Results:

  • Developed four CDMs and a comprehensive CDM-driven dosing strategy for vancomycin therapy.
  • CDM demonstrated superior clinical efficacy prediction with a higher AUC_R (0.807) compared to FDM (0.688).
  • Predicted empirical vancomycin dosages for six *Staphylococci* populations and four strains across various creatinine clearance rates (CLcr).

Conclusions:

  • CDM is a valuable individualized dose model that addresses limitations of current TDM and Bayesian forecasting.
  • Offers a practical approach for individualized and dynamic vancomycin administration.
  • Successfully achieved individualized, dynamic, and full-course vancomycin dose prediction, supporting quantitative and personalized drug research.